The current report says the sample was received on March 20, 2026, and reported on March 22, 2026
dose-dependent GI adverse events (nausea, vomiting) similar to other amylin analogues Exposure: Dose-proportional increases in Cmax and AUC Gastric Effects: Dose-dependent slowing of gastric emptying confirmed via paracetamol absorption test Appetite Suppression: Reduced ad libitum food intake at doses 1.2 mg Clinical Significance: Established feasibility of once-weekly dosing and identified dose range for Phase 2 studies
Its a game of theyre gripping each other and then, you know, its a lot about strength and its a lot about technique, but its not about closing distance
El Sahly says that it only happens in a small fraction of people
While not FDA-approved for longevity enhancement, its used in supervised medical protocols for healthspan optimization and biological age management
These effects suggest potential applications in peripheral neuropathies and traumatic nerve injuries, though human efficacy data remains limited